Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Dusseldorf - Delayed Quote EUR

Cytokinetics Inc (KK3A.DU)

Compare
44.00
0.00
(0.00%)
As of 12:30:58 PM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,219
7,530
94,588
70,428
55,828
Cost of Revenue
330,755
330,123
240,813
159,938
96,951
Gross Profit
-327,536
-322,593
-146,225
-89,510
-41,123
Operating Expense
197,090
173,612
177,977
96,803
52,820
Operating Income
-524,626
-496,205
-324,202
-186,313
-93,943
Net Non Operating Interest Income Expense
-36,876
-30,039
-39,814
-29,001
-33,347
Other Income Expense
--
--
-24,939
--
--
Pretax Income
-576,402
-526,244
-388,955
-215,314
-127,290
Net Income Common Stockholders
-576,402
-526,244
-388,955
-215,314
-127,290
Diluted NI Available to Com Stockholders
-576,402
-526,244
-388,955
-215,314
-127,290
Basic EPS
-5.38
-5.45
-4.33
-2.80
-1.97
Diluted EPS
-5.38
-5.45
-4.33
-2.80
-1.97
Basic Average Shares
107,223.50
96,524
89,825
76,886
64,524
Diluted Average Shares
107,223.50
96,524
89,825
76,886
64,524
Total Operating Income as Reported
-524,626
-496,205
-324,202
-186,313
-93,943
Total Expenses
527,845
503,735
418,790
256,741
149,771
Net Income from Continuing & Discontinued Operation
-576,402
-526,244
-388,955
-215,314
-127,290
Normalized Income
-576,502
-526,244
-364,016
-215,314
-127,290
Interest Income
44,106
27,629
11,342
331
5,329
Interest Expense
80,982
57,668
51,156
29,332
38,676
Net Interest Income
-36,876
-30,039
-39,814
-29,001
-33,347
EBIT
-495,420
-468,576
-337,799
-185,982
-88,614
EBITDA
-481,937
-456,684
-331,985
-183,706
-86,783
Reconciled Cost of Revenue
330,755
330,123
240,813
159,938
96,951
Reconciled Depreciation
13,483
11,892
5,814
2,276
1,831
Net Income from Continuing Operation Net Minority Interest
-576,402
-526,244
-388,955
-215,314
-127,290
Total Unusual Items Excluding Goodwill
100
--
-24,939
--
--
Total Unusual Items
100
--
-24,939
--
--
Normalized EBITDA
-482,037
-456,684
-307,046
-183,706
-86,783
12/31/2020 - 7/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2VJ.DU Ascletis Pharma Inc
0.7700
+4.76%
 
2VJ.BE Ascletis Pharma Inc
0.8200
+6.49%
 
ASCLF Ascletis Pharma Inc.
0.8388
0.00%
 
1VT.BE Viking Therapeutics Inc
27.24
-0.11%
 
1672.HK ASCLETIS-B
6.750
+8.87%
 
EWTX Edgewise Therapeutics, Inc.
25.08
+0.28%
 
ATNM Actinium Pharmaceuticals, Inc.
1.1500
-1.71%
 
BMEA Biomea Fusion, Inc.
2.8400
-14.97%
 
AKRO Akero Therapeutics, Inc.
47.47
-4.29%
 
ALT Altimmune, Inc.
5.91
-3.27%